|
Volumn 24, Issue 8, 2005, Pages 980-984
|
Efficacy of gefitinib on Chinese patients with locally advanced or metastatic non-small cell lung cancer: a clinical trial
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GEFITINIB;
QUINAZOLINE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
DRUG ANTAGONISM;
FEMALE;
HUMAN;
LIVER TUMOR;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
METASTASIS;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOLOGY;
PRURITUS;
RASH;
SURVIVAL RATE;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
DISEASE-FREE SURVIVAL;
EXANTHEMA;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PRURITUS;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
SURVIVAL RATE;
|
EID: 34548080876
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (23)
|
References (0)
|